advertisement
Abstract #108295 Published in IGR 23-4
Findings from a Statewide Teleretina Diabetic Retinopathy Screening Program in Arkansas
Shirey M; Kwok A; Jenkins H; Uwaydat SInternational journal of telemedicine and applications 2023; 2023: 3233803
INTRODUCTION: A significant proportion of diabetic patients in the United States do not present for annual dilated eye exams to monitor for signs of diabetic retinopathy (DR). The purpose of this study was to analyze the results of a statewide, multiclinic teleretina program designed to screen rural Arkansans for this sight-debilitating disease. METHODS: Patients with diabetes seen at 10 primary care clinics across Arkansas were offered teleretinal-imaging services. Images were transmitted to the University of Arkansas for Medical Sciences' (UAMS) Harvey and Bernice Jones Eye Institute (JEI) for grading and recommendations for further treatment. RESULTS: From February 2019 to May 2022, 668 patients underwent imaging; 645 images were deemed of sufficient quality to generate an interpretation. 541 patients had no evidence of DR, while 104 patients had some evidence of DR. 587 patients had no evidence of maculopathy, while 58 patients had some evidence of maculopathy on imaging. 246 patients had other pathology evident on imaging, with the most common being hypertensive retinopathy, glaucoma suspects, and cataracts. In a rural, primary care setting, the JEI teleretina program identifies DR and other nondiabetic ocular pathologies, allowing for an appropriate triage for eye care for patients in a predominantly rural state.
University of Arkansas for Medical Sciences: Harvey and Bernice Jones Eye Institute, Little Rock, AR 72205, USA.
Full article